Literature DB >> 19880291

F2-isoprostanes and total radical-trapping antioxidant potential in preterm infants receiving parenteral lipid emulsions.

Paola Roggero1, Fabio Mosca, Maria Lorella Giannì, Anna Orsi, Orsola Amato, Elisabetta Migliorisi, Mariangela Longini, Giuseppe Buonocore.   

Abstract

OBJECTIVE: We assessed the effects of three different parenteral lipid emulsions (long-chain triacylglycerols, medium-chain/long-chain triacylglycerols, olive oil) on lipid peroxidation in preterm infants. The hypothesis to be tested was that preterm infants receiving the olive oil-based lipid emulsion would undergo less peroxidation than preterm infants receiving lipid emulsions based on long- or medium-chain triacylglycerols. The secondary aim was to evaluate whether the lipid peroxidation persists beyond the cessation of parenteral nutrition (PN).
METHODS: A randomized controlled trial was designed. Thirty-six consecutive preterm infants (gestational age 28-33 wk) were enrolled in the study. Preterm infants were randomized to receive one of the three emulsions within the first 24h of life. Plasma F2-isoprostanes (F2-Ip) and total radical-trapping antioxidant potential (TRAP) were determined at baseline, on day 7 of PN, and on day 7 after stopping PN.
RESULTS: The F2-Ip and TRAP concentrations were not statistically different within and among the three groups at any time of the study. No significant interaction effect between the type of lipid emulsion administered and the repeated values of F2-Ip and TRAP was found. F2-Ip values showed a trend to decrease throughout the study in all the three groups.
CONCLUSION: No significant difference in oxidative stress of preterm infants was detected according to the type of lipid emulsion received. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880291     DOI: 10.1016/j.nut.2009.06.018

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  5 in total

Review 1.  Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Meredith A Baker; Gillian L Fell; Mark Puder; Kathleen M Gura
Journal:  Nutr Clin Pract       Date:  2016-08-16       Impact factor: 3.080

2.  Kinetic stability of all-in-one parenteral nutrition admixtures in the presence of high dose Ca2+ additive under clinical application circumstances.

Authors:  István G Télessy; Judith Balogh; Barnabás Szabó; Ferenc Csempesz; Romána Zelkó
Journal:  Nutr J       Date:  2012-05-16       Impact factor: 3.271

3.  Lipid emulsions for parenterally fed preterm infants.

Authors:  Vishal Kapoor; Manoj N Malviya; Roger Soll
Journal:  Cochrane Database Syst Rev       Date:  2019-06-04

Review 4.  Biological and Clinical Aspects of an Olive Oil-Based Lipid Emulsion-A Review.

Authors:  Wei Cai; Phillip C Calder; Maria F Cury-Boaventura; Elisabeth De Waele; Julie Jakubowski; Gary Zaloga
Journal:  Nutrients       Date:  2018-06-15       Impact factor: 5.717

5.  Standardised neonatal parenteral nutrition formulations - an Australasian group consensus 2012.

Authors:  Srinivas Bolisetty; David Osborn; John Sinn; Kei Lui
Journal:  BMC Pediatr       Date:  2014-02-18       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.